Skip to search.
 TSX Down 0.31% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Dyax Corp. (DYAX)

-NasdaqGM

3.17 Down 0.06(1.86%) 10:08AM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:3.23
Open:N/A
Bid:3.20 x 700
Ask:3.22 x 200
1y Target Est:4.67
Beta:0.81
Next Earnings Date:15-Jul-13DYAX Earnings announcement
Day's Range:3.20 - 3.22
52wk Range:2.02 - 4.50
Volume:12,635
Avg Vol (3m):730,098
Market Cap:317.81M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
DYAXDown 1.86%317.81M
RHHBYN.MXUp 1.64%2.74T
SHP.LDown 0.10%11.50B
SUNPHARMA.NSDown 1.10%992.21B
GILD.MXUp 2.37%1.02T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.27
Quarterly EPS Est (Jun-13) :-0.06
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-2.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, engages in the identification, development, and commercialization of treatments for plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback